Outpatient treatment of osteomyelitis with telavancin.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2017.01.034
Abstract: Telavancin is a lipoglycopeptide antibiotic with bactericidal activity against Gram-positive pathogens including Staphylococcus aureus, the most frequent cause of osteomyelitis. Treatment is often challenging due to needs for surgical intervention along with prolonged administration of… read more here.
Keywords: treatment; osteomyelitis telavancin; outpatient treatment; treatment osteomyelitis ... See more keywords